Conflict disrupts global supply chains for cancer medicines

The Lancet Oncology 2026

View at publisher

Authors: Paul Adepoju

DOI: 10.1016/s1470-2045(26)00138-5

Cited by: 2

Fields of Study & Subjects

Pharmaceutical Economics and Policy Safe Handling of Antineoplastic Drugs Pharmaceutical Quality and Counterfeiting